Issue 2/2019
Including PIH articles on Epigenetic abnormalities and therapies for hematological malignancies
Content (18 Articles)
Familial case of hereditary Pelger-Huët anomaly
Tatsuya Konishi, Hideharu Muto, Ryoko Sakuma, Shuichi Miyawaki, Kazuteru Ohashi, Noriko Doki, Junji Tomiyama
Detection of Jordans’ anomaly using compact-type automated hematology analyzer
Tohru Inaba, Keita Okumura, Naohisa Fujita, Akira Suzuki, Ken-ichi Hirano
Epigenetic abnormalities and therapies for hematological malignancies
Toshio Kitamura
New insights into the biology of acute myeloid leukemia with mutated NPM1
Lorenzo Brunetti, Michael C. Gundry, Margaret A. Goodell
Clinical update on hypomethylating agents
Matthieu Duchmann, Raphael Itzykson
Deregulated Polycomb functions in myeloproliferative neoplasms
Goro Sashida, Motohiko Oshima, Atsushi Iwama
Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms
Shuhei Asada, Toshio Kitamura
Hematologic recovery induced by eltrombopag in Japanese patients with aplastic anemia refractory or intolerant to immunosuppressive therapy
Hirohito Yamazaki, Kensuke Ohta, Hiroatsu Iida, Kazunori Imada, Naoshi Obara, Yukihiro Tokumine, Yoshiaki Tomiyama, Kensuke Usuki, Kenji Imajo, Koichi Miyamura, Osamu Sasaki, Zhang Fanghong, Toshihiro Hattori, Takeshi Tajima, Akira Matsuda, Shinji Nakao
Lupus anticoagulant-hypoprothrombinemia syndrome and similar diseases: experiences at a single center in Japan
Masahiro Ieko, Mika Yoshida, Sumiyoshi Naito, Kazumasa Ohmura, Nobuhiko Takahashi
Expression of mitochondrial genes predicts survival in pediatric acute myeloid leukemia
Anudishi Tyagi, Raja Pramanik, Radhika Bakhshi, Archna Singh, Sreenivas Vishnubhatla, Sameer Bakhshi
Binimetinib, a novel MEK1/2 inhibitor, exerts anti-leukemic effects under inactive status of PI3Kinase/Akt pathway
Kanae Sakakibara, Takayuki Tsujioka, Jun-ichiro Kida, Nami Kurozumi, Takako Nakahara, Shin-ichiro Suemori, Akira Kitanaka, Yujiro Arao, Kaoru Tohyama
Impact of chromosomal abnormalities on the efficacy of lenalidomide plus dexamethasone treatment in patients with relapsed/refractory multiple myeloma
Takashi Yoshida, Masaki Ri, Haruna Fujinami, Yoshiko Oshima, Takuto Tachita, Yoshiaki Marumo, Hirokazu Sasaki, Shiori Kinoshita, Haruhito Totani, Tomoko Narita, Ayako Masaki, Asahi Ito, Shigeru Kusumoto, Takashi Ishida, Hirokazu Komatsu, Shinsuke Iida
Characteristics of palliative home care for patients with hematological tumors compared to those of patients with solid tumors
Takashi Ishida, Kota Ohashi, Chikako Okina, Shiho Ohashi, Sosei Okina, Koji Miyazaki, Takahiro Suzuki
The current state of human immunodeficiency virus-associated lymphoma in Japan: a nationwide retrospective study of the Japanese Society of Hematology Blood Disease Registry
Shotaro Hagiwara, Hirokazu Nagai, Junji Tanaka, Seiji Okada
Hereditary spherocytosis caused by copy number variation in SPTB gene identified through targeted next-generation sequencing
Woori Jang, Jiyeon Kim, Hyojin Chae, Myungshin Kim, Kyung-Nam Koh, Chan-Jeoung Park, Yonggoo Kim
Glucocorticoids promote response to thrombopoietin-receptor agonists in refractory ITP: a case series
Jacqueline N. Poston, Terry B. Gernsheimer
Macrophage elimination in bone marrow by dexamethasone palmitate is associated with successful engraftment in patients with hemophagocytic syndrome
Hiroyuki Sugiura, Ken-ichi Matsuoka, Masayuki Matsuda, Shuntaro Ikegawa, Tomoko Inomata, Taiga Kuroi, Takeru Asano, Shohei Yoshida, Hisakazu Nishimori, Keiko Fujii, Nobuharu Fujii, Yoshinobu Maeda